News

The Wisk, Insitu and SkyGrid acquisition still needs other regulatory approvals before a year-end close

Plus: British Columbia sues OpenAI over mass school shooting and executives flock to New York to tout lowering emissions.

Paramount's agreement with 12 state attorneys general paves the way for the company to complete its $110 billion acquisition of Warner Bros. Discovery.

Sept 21 (Reuters) - Paramount Skydance has settled with California and 11 other states that sued to block its $110 billion acquisition of Warner Bros Discovery, a ‌source familiar with the matter said on Monday, clearing one of the last ‌hurdles to a deal that would reshape Hollywood. The settlement includes the creation of independent editorial boards for CNN and CBS, ​the source said, a move aimed at safeguarding the independence of their news operations under the combined company.

Paramount won’t have to sell cable channels under the $81 billion merger poised to reshape Hollywood.

Both stocks jumped about 7% Monday morning after reports that Paramount Skydance and the California attorney general met to discuss a settlement.

FDA clearance for Abbott’s TactiFlex Duo follows the dual ablation catheter’s receipt of a European CE mark in January 2026.

Fox (FOX) is facing expanded antitrust scrutiny from the US Department of Justice over its $22 billi

Gilead Sciences is branching out beyond its HIV franchise into oncology and immunology therapies.

Alphabet stock soared the last time a judge rejected the Justice Department's bid to force it to sell part of its business.

Citi said continued advertiser spending and accelerating AI demand at AWS support its bullish view of Amazon.

The chip giant stepped back from the AI Compute Partnership program last week, less than two months after announcing it in July

The company is changing how it enforces its site reputation policy within the European Economic Area, to appease regulators and avoid a potentially hefty fine.

The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories’ Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for diabetes patients aged two and older. The regulatory nod makes the device the first wearable in the...

KKR & Co. (NYSE:KKR) is set to pay a $250 million civil penalty after the private equity firm allegedly violated the Hart-Cottrell-Rodino Act by withholding and altering documents and failing to make required filings. The HSR Act requires M&A parties...

The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories’ (NYSE:ABT) Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for diabetes patients aged two and older. The regulatory nod makes the device the first wearable in the U.S. to monitor ketone levels continuously. It also represents the first global system to track blood sugar and ketones simultaneously within a single unit. Clinical Data And De Novo Pathway The agency granted marketing authorization

The Food and Drug Administration cleared a blood test for identifying Alzheimer’s disease symptoms, which was developed by Roche and Eli Lilly.

Apple is changing its fee structure for app developers in the European Union after years of regulatory pressure over its App Store practices.

Apple has agreed to major concessions in Europe to resolve regulatory antitrust disputes, replacing its controversial per-install download fee.

Apple seeks to end a yearslong antitrust dispute over how the tech company manages its devices and App Store that included a $579 million fine.

Makan Delrahim made the disclosure at Politico’s California Agenda conference, according to Reuters, signaling that Paramount is willing to go beyond internal safeguards to salvage a deal that has become one of the most politically charged media mergers in years. Warner Bros. Discovery is the publicly traded parent of CNN (NASDAQ: WBD), and the merger’s fate directly determines whether Ellison’s Paramount consolidates control over both CBS News and the cable network.

mFLUSIVA is now the first and only mRNA standalone seasonal influenza vaccine on the market, marking a major advancement for the field.

Firefox developer Mozilla is warning that it could be forced to "exit the browser and browser engine markets" if it can no longer receive payment from Google for distributing its search engine.

Dismissal removes one legal challenge involving compounded alternatives while Novo confronts intensifying commercial competition in obesity treatments.

A Texas judge dismissed claims that the drugmakers illegally blocked access to compounded weight-loss drugs.

Moderna has secured FDA approval for its flu vaccine mFLUSIVA. But does that warrant buying MRNA shares today? Let’s find out!

Moderna (NASDAQ:MRNA) announced on Thursday that the U. S.

The Food and Drug Administration approved Moderna’s mRNA-based flu vaccine for adults ages 50 and older, clearing the first shot of its kind after a review process that nearly collapsed in February. The vaccine, called mFlusiva, uses the same mRNA technology as Moderna’s Covid-19 shots. It could reach pharmacies in time for the coming flu season, which typically starts in the fall.

(Update with New Jersey Attorney General Jennifer Davenport's statement on the lawsuit in the penult

A European court rejected Broadcom's attempt to block regulators from demanding U.S.-based VMware legal documents.